Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis Juan Francisco Navarro-González; Alberto Ortiz; Ana Cebrián Cuenca; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;

The implementation of cardionephrology in Spain is a health emergency Borja Quiroga; Javier Díez;

Prediabetes and CKD: Does a causal relationship exist Jorge Rico Fontalvo; María José Soler; Rodrigo Daza Arnedo; Guillermo Navarro-Blackaller; Ramón Medina-González; Tomas Rodríguez Yánez; Maria Cardona-Blanco; Jose Cabrales-Juan; Isabella Uparrela-Gulfo; Jonathan S. Chávez-Iñiguez;